This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

STANLEY SLATER, M.D.

AMA Arch Intern Med. 1956;98(2):175-180.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Much confusion exists regarding the management of nodular goiters. The problem which confronts the clinician is whether to surgically remove asymptomatic thyroid nodules solely because of their possible malignancy. The statistics derived from series of surgically treated glands indicate a significant percentage of cancers in both clinically uninodular and clinically multinodular nontoxic goiters.¹ As long as surgeons continue to be presented with the same selection of nodular goiters as has been responsible for these statistics, surgery for such goiters seems indicated. It has been pointed out that these data represent the findings in a selected group of nodular goiters, the selection having been performed by the patient himself, the family physician, and surgeon.² The unanswered question at present is what is the frequency of carcinoma in unselected nodular goiters. Sokal ³ and others have suggested that the percentage of malignancies in an unselected group of nodular goiters would . . . [Full Text PDF of this Article]

Author Affiliations
Brooklyn

From the Departments of Medicine of the Bay Ridge Medical Group and the State University of New York College of Medicine at New York City, Brooklyn, and the Medical Services of the Maimonides Hospital of Brooklyn.

Footnotes
Submitted for publication Feb. 10, 1956.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?